{"id":"W2130730771","doi":"10.1634/theoncologist.2007-0245","title":"Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases","year":2010,"lang":"en","type":"article","venue":"The Oncologist","topic":"Bone health and treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Novartis Pharmaceuticals Corporation; Amgen","keywords":"Medicine; Denosumab; Zoledronic acid; Breast cancer; Clinical trial; Osteonecrosis of the jaw; Internal medicine; Multiple myeloma; Oncology; Adverse effect; Cancer; Surgery; Osteoporosis; Bisphosphonate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004479617,0.0003072233,0.001452483,0.0006139276,0.0002839077,0.0008839942,0.0002517661,0.0007925319,0.003625366],"category_scores_gemma":[0.01227695,0.0001195803,0.001730103,0.0007539066,0.0002015315,0.0007209369,0.0004828396,0.001253848,0.0004568872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006955085,"about_ca_system_score_gemma":0.001139041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008330795,"about_ca_topic_score_gemma":0.002073411,"domain_scores_codex":[0.9970872,0.001736075,0.00045245,0.0001241271,0.0004875324,0.0001125786],"domain_scores_gemma":[0.9957177,0.002509266,0.000990015,0.00009544195,0.000435317,0.0002522638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02269786,0.001109008,0.02489833,0.01641241,0.004000999,0.0003153841,0.0002695468,0.001330704,0.003094174,0.003048781,0.01120494,0.9116178],"study_design_scores_gemma":[0.05597525,0.06291068,0.3970377,0.03514456,0.03522504,0.006309385,0.001625945,0.005367961,0.0110289,0.03645466,0.3525671,0.0003528354],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1554058,0.8044807,0.002422163,0.01717494,0.0008227074,0.0008300623,0.000683128,0.0000734104,0.01810697],"genre_scores_gemma":[0.8190455,0.1610015,0.00738176,0.007807422,0.00136611,0.0007138103,0.000663572,0.00002417579,0.001996129],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004479617,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0494458585787789,"score_gpt":0.3779195865178927,"score_spread":0.3284737279391138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}